Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial
PaperCitations, authors & open-access status
Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 77 citations, 2023 year and green oa status.
77
Citations
2023
Year
green
OA Status